Vasamed (Vasamed) EPS (Basic) : $-1.49 (TTM As of Sep. 2006)

View and export this data going back to 1996. Start your Free Trial

What is Vasamed EPS (Basic)?

Vasamed's basic earnings per share (Basic EPS) for the three months ended in Sep. 2006 was $-0.45. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2006 was $-1.49.

Vasamed's EPS (Diluted) for the three months ended in Sep. 2006 was $-0.45. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2006 was $-1.49.

Vasamed's EPS without NRI for the three months ended in Sep. 2006 was $-0.45. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2006 was -1.46.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Vasamed EPS (Basic) Historical Data

The historical data trend for Vasamed's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vasamed EPS (Basic) Chart

Vasamed Annual Data

Trend

Dec96

Dec97

Dec98

Dec99

Dec00

Dec01

Dec02

Dec03

Dec04

Dec05

EPS (Basic)

Get a 7-Day Free Trial

-2.24

-0.67

-0.71

-1.85

-1.84

Vasamed Quarterly Data
	Dec01	Mar02	Jun02	Sep02	Dec02	Mar03	Jun03	Sep03	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06
EPS (Basic)	Get a 7-Day Free Trial															-0.53	-0.25	-0.35	-0.44	-0.45

Vasamed EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Vasamed's Basic EPS for the fiscal year that ended in Dec. 2005 is calculated as

Basic EPS (A: Dec. 2005 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-4.888	-	1.964)	/	3.718
	=	-1.84

Vasamed's Basic EPS for the quarter that ended in Sep. 2006 is calculated as

Basic EPS (Q: Sep. 2006 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-1.716	-	0)	/	3.855
	=	-0.45

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2006 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.49

Vasamed (OTCPK:VSMD) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Vasamed EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Vasamed's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Vasamed (Vasamed) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vasamed Inc (OTCPK:VSMD) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

7615 Golden Triangle Drive, Suite A, Eden Prairie, MN, USA, 55344-3733

Website

http://www.vasamed.com

Vasamed Inc develops, manufactures and markets low-cost, non-invasive peripheral and cardiovascular diagnostic systems for hemodynamic assessment.

Vasamed (Vasamed) Headlines

No Headlines